The Lancet Haematology

Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trial.

Pub Date : 2025-05-02 DOI: 10.1016/s2352-3026(25)00071-7 Xin-Yue Wang,Xi-Mei Zhang,Liang Wang,Lin-Rui Gao,Ke Chen,Xiao-Li Feng,Wei Rao,Rong Zheng,Yun-Peng Wu,Yong-Wen Song,Hui Fang,Bo Chen,Jing Jin,Yue-Ping Liu,Hao Jing,Yuan Tang,Wen-Wen Zhang,Yi-Rui Zhai,Ning-Ning Lu,Ning Li,Chang-Fa Xia,Shu-Lian Wang,Xin Liu,Ye-Xiong Li,Shu-Nan Qi

Myelodysplastic syndrome initially presenting as thrombotic microangiopathy-like rapid cytopenia with schistocytes.

Pub Date : 2025-05-01 DOI: 10.1016/s2352-3026(25)00047-x Shin Lee,Kei Fujita,Ryo Sugiyama,Takuya Sobajima,Takeshi Hara,Hisashi Tsurumi

Early rituximab monotherapy versus watchful waiting for advanced stage, asymptomatic, low tumour burden follicular lymphoma: long-term results of a randomised, phase 3 trial.

Pub Date : 2025-05-01 DOI: 10.1016/s2352-3026(25)00034-1 Michael Northend,William Wilson,Kushani Ediriwickrema,Laura Clifton-Hadley,Wendi Qian,Zaynab Rana,Tanya-Louise Martin,William Townsend,Moya Young,Fiona Miall,David Cunningham,Jan Walewski,Burhan Ferhanoglu,Kim Linton,Amanda Johnston,John F Seymour,David C Linch,Kirit M Ardeshna